Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
30.4M
-
Shares change
-
+713K
-
Total reported value, excl. options
-
$832M
-
Value change
-
+$19.9M
-
Put/Call ratio
-
0.19
-
Number of buys
-
95
-
Number of sells
-
-67
-
Price
-
$27.36
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2016
208 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2016.
REPLIGEN CORP - COMMON STOCK (RGEN) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.4M shares
of 56.2M outstanding shares and own 54.06% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (2.55M shares), OppenheimerFunds, Inc. (1.89M shares), Invesco Ltd. (1.82M shares), VANGUARD GROUP INC (1.57M shares), FMR LLC (1.52M shares), RENAISSANCE TECHNOLOGIES LLC (1.12M shares), Conestoga Capital Advisors, LLC (1.06M shares), DIMENSIONAL FUND ADVISORS LP (1.05M shares), STATE STREET CORP (944K shares), and BlackRock Institutional Trust Company, N.A. (900K shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.